Korean contract development and manufacturing organizations (CDMOs) are set to engage with global drugmakers at the upcoming ...

Samsung Biologics (KRX: 207940.KS), a global contract development and manufacturing organization (CDMO), today announced its ...

Samsung Group has 22 affiliates listed on the local stock market, including Samsung Electronics Co., Samsung Biologics Co., ...

Samsung Biologics earns spot on Dow Jones Sustainability Index for fourth year Samsung Biologics maintains its position in ...

Biomedicines ("Generate") as part of its efforts to drive growth and innovation in the biopharmaceutical sector. The ...

SEOUL, Dec. 30 (Korea Bizwire) — Samsung Group, South Korea’s largest conglomerate, has seen its market capitalization ...

Samsung Group's market capitalization has decreased by over 160 trillion won this year. According to the financial investment ...

Threading quality into every step: One-stop manufacturing at Samsung Biologics Samsung Biologics, a fully integrated CDMO, is dedicated to ensuring high-quality production through its ...

Samsung invests in Generate to advance AI-driven protein therapeutics discovery: Incheon, South Korea Saturday, December 21, 2024, 17:00 Hrs [IST] Samsung announced that it has in ...

Samsung Biologics has signed a contract worth 111.2 billion won with an undisclosed U.S. pharmaceutical firm to provide ...